Copyright
©The Author(s) 2021.
World J Gastroenterol. Dec 14, 2021; 27(46): 7982-7994
Published online Dec 14, 2021. doi: 10.3748/wjg.v27.i46.7982
Published online Dec 14, 2021. doi: 10.3748/wjg.v27.i46.7982
Figure 1 rSj16 protects against acute dextran sulfate sodium-induced colitis.
A: Daily changes in body weight [dextran sulfate sodium (DSS) + rSj16 vs DSS + PBS]; B: Changes in DAI (DSS + rSj16 vs DSS + PBS); C and D: Colon lengths were measured and recorded; E: Macroscopic appearance of the colons; F: The histopathological changes in the colons were examined by H&E staining (20×); G: Histopathological scores of the colons were determined. DSS: Dextran Sulfate Sodium Salt. Statistical analysis was performed using one-way ANOVA. Data are presented as means ± SD; aP < 0.05, bP < 0.01, cP < 0.001.
- Citation: Zhang LC, Wu XY, Yang RB, Chen F, Liu JH, Hu YY, Wu ZD, Wang LF, Sun X. Recombinant protein Schistosoma japonicum-derived molecule attenuates dextran sulfate sodium-induced colitis by inhibiting miRNA-217-5p to alleviate apoptosis. World J Gastroenterol 2021; 27(46): 7982-7994
- URL: https://www.wjgnet.com/1007-9327/full/v27/i46/7982.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i46.7982